Steve Petrou

Co-Founder & Chief Scientific Officer @ Praxis Precision Medicines arrow icon

About Steve Petrou

Steve Petrou is the Co-Founder and Chief Scientific Officer who specializes in ion channel neuropathies in rare pediatric epilepsies and other neurodevelopmental disorders.

Known information

Steve Petrou holds a B.S. in zoology and genetics and a Ph.D. in zoophysiology from the University of Melbourne. He serves as the Director and Head of the Department at the Florey Institute of Neuroscience and Mental Health, and also leads the Ion Channels and Human Disease Laboratory. Recognized as a leader in his field, Petrou’s research primarily focuses on the functional genetics and genomics of epilepsy, mechanisms of disease, and the development and evaluation of animal models and precision medicine approaches for genetic epilepsy.

About Praxis Precision Medicines

Praxis Precision Medicines is a biotechnology company based in Boston, Massachusetts, specializing in developing precision therapies for central nervous system disorders using human genetics and translational tools.

report flag Report inaccurate information

People similar to Steve Petrou

Marcio Souza

President & Chief Executive Officer @ Praxis Precision Medicines

Marcio Souza is the President & CEO of PTC Therapeutics, with a background in pharmacy and business, and experience across several biopharmaceutical companies.

Karl Hansen

Chief Technical Operations Officer @ Praxis Precision Medicines

Karl Hansen is the Chief Technical Operations Officer with a robust background in chemistry and pharmaceuticals, including significant roles at Boston Pharmaceuticals and Amgen.

Brian Spar is a seasoned project management professional in the pharmaceutical and biotech industries, currently serving as Chief of Staff and previously holding key roles at BioCryst Pharmaceuticals and PTC Therapeutics.

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free